TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY APPLICATION (USD BILLION)
6.1. Oncology
6.2. Cardiology
6.3. Neurology
6.4. Endocrinology
7. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY RADIOISOTOPE (USD BILLION)
7.1. Fluorine-18 (18F)
7.2. Carbon-11 (11C)
7.3. Nitrogen-13 (13N)
7.4. Gallium-68 (68Ga)
8. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY MODALITY (USD BILLION)
8.1. PET (Positron Emission Tomography)
8.2. SPECT (Single-Photon Emission Computed Tomography)
8.3. SPECT/CT (Single-Photon Emission Computed Tomography/Computed Tomography)
8.4. PET/CT (Positron Emission Tomography/Computed Tomography)
9. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY TARGET DISEASE (USD BILLION)
9.1. Cancer
9.2. Cardiovascular Disease
9.3. Neurological Disorders
9.4. Endocrine Disorders
10. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Radiopharmaceutical Theranostics Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Radiopharmaceutical Theranostics Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Toshiba Medical Systems
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Nordion
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Radiomedix
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Lantheus Holdings
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Mylan
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Sirtex Medical
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Cardinal Health
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. IBA
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. GE Healthcare
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Merck KGaA
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Philips Healthcare
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Novartis
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Bayer
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Telix Pharmaceuticals
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 8. US RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 9. US RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 10. US RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 11. US RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 28. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 29. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 30. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 31. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 58. APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 59. APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 60. APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 61. APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 128. MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 129. MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 130. MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 131. MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY RADIOISOTOPE, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY MODALITY, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TARGET DISEASE, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS
FIGURE 3. US RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 4. US RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 5. US RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 6. US RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 7. US RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 9. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 10. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 11. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 12. CANADA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS
FIGURE 14. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 15. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 16. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 17. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 18. GERMANY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 20. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 21. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 22. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 23. UK RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 25. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 26. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 27. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 28. FRANCE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 30. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 31. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 32. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 33. RUSSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 35. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 36. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 37. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 38. ITALY RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 40. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 41. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 42. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 43. SPAIN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 45. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 46. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 47. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 48. REST OF EUROPE RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS
FIGURE 50. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 51. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 52. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 53. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 54. CHINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 56. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 57. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 58. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 59. INDIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 61. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 62. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 63. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 64. JAPAN RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 66. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 67. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 68. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 69. SOUTH KOREA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 71. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 72. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 73. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 74. MALAYSIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 76. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 77. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 78. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 79. THAILAND RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 81. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 82. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 83. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 84. INDONESIA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 86. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 87. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 88. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 89. REST OF APAC RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS
FIGURE 91. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 92. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 93. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 94. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 95. BRAZIL RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 97. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 98. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 99. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 100. MEXICO RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 102. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 103. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 104. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 105. ARGENTINA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 107. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 108. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 109. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 110. REST OF SOUTH AMERICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 113. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 114. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 115. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 116. GCC COUNTRIES RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 118. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 119. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 120. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 121. SOUTH AFRICA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY APPLICATION
FIGURE 123. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE
FIGURE 124. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY MODALITY
FIGURE 125. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY TARGET DISEASE
FIGURE 126. REST OF MEA RADIOPHARMACEUTICAL THERANOSTICS MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF RADIOPHARMACEUTICAL THERANOSTICS MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF RADIOPHARMACEUTICAL THERANOSTICS MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: RADIOPHARMACEUTICAL THERANOSTICS MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: RADIOPHARMACEUTICAL THERANOSTICS MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: RADIOPHARMACEUTICAL THERANOSTICS MARKET
FIGURE 133. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 134. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 135. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY RADIOISOTOPE, 2024 (% SHARE)
FIGURE 136. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY RADIOISOTOPE, 2019 TO 2032 (USD Billions)
FIGURE 137. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY MODALITY, 2024 (% SHARE)
FIGURE 138. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY MODALITY, 2019 TO 2032 (USD Billions)
FIGURE 139. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY TARGET DISEASE, 2024 (% SHARE)
FIGURE 140. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY TARGET DISEASE, 2019 TO 2032 (USD Billions)
FIGURE 141. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. RADIOPHARMACEUTICAL THERANOSTICS MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
